Main Session
Sep 28
QP 12 - Molecular Biomarkers and Precision Oncology in CNS Tumors

1069 - SETD2 Loss Enhances Radiosensitivity and Predicts Improved Survival in High-Grade Gliomas

05:35pm - 05:40pm ET
Room 153

Presenter(s)

Won Young Suh, MD - Seoul National University Hospital, Seoul, SEO